Esaote North America Announces a Multi-Year Contract with Vizient

Esaote North America announces a multi-year contract with Vizient, Inc., the nation’s largest member-driven healthcare performance improvement company, serving more than 50% of the nation’s acute care providers.

Esaote North America said the new agreement provides Vizient members access to contracts that offer increased savings on Esaote North America’s comprehensive Ultrasound product line and services, including the widely popular MyLabTM family portfolio.

“Our unique ultrasound portfolio is optimized for high performance in the most demanding clinical settings, covering a broad spectrum of clinical applications without compromising image quality or workflow efficiency,” said Robert Lewis, President and General Manager at Esaote North America.

Esaote North America is an internationally recognized leader that provides superior Ultrasound point-of-care solutions, Dedicated MRI systems, and Healthcare IT workflow solutions. Esaote’s founding philosophies continue to push the technological boundaries of the medical device industry, delivering cost-effective and eco-friendly diagnostic imaging solutions that meet customers’ needs worldwide.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”